Despite validated p-tau217 blood tests for early Alzheimer’s prediction, clinical adoption lags due to lack of interventions and standardized protocols. Blood biomarker p-tau217 can predict Alzh...
A new blood test based on p-tau217 biomarker can predict Alzheimer’s symptom onset in 3-4 years with high accuracy, offering early intervention opportunities. Recent studies validate a p-tau217 ...